1-4 of 4
Boris van der Zouwen
Close
Sort by
Journal Articles

HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion

Sanja Stevanović, Cornelis A. M. van Bergen, Simone A. P. van Luxemburg-Heijs, Boris van der Zouwen, Ekaterina S. Jordanova, Alwine B. Kruisselbrink, Marian van de Meent, Jessica C. Harskamp, Frans H. J. Claas, Erik W. A. Marijt, Jaap Jan Zwaginga, Constantijn J. M. Halkes, Inge Jedema, Marieke Griffioen, J. H. Frederik Falkenburg
Journal: Blood
Blood (2013) 122 (11): 1963–1973.
https://doi.org/10.1182/blood-2012-12-470872
Published: 2013
Includes: Supplemental data
Journal Articles

Collateral Damage of Non-Hematopoietic Tissue by Hematopoiesis-Specific T Cells Results in GvHD During An Ongoing Profound Gvl Reaction,

Boris van der Zouwen, MD, Alwine Kruisselbrink, J.H. Frederik Falkenburg, Inge Jedema, PhD
Journal: Blood
Blood (2011) 118 (21): 4031.
https://doi.org/10.1182/blood.V118.21.4031.4031
Published: 2011
Journal Articles

Potent Alloreactive Effector T Cells Cause Limited Damage to Non-Hematopoietic Tissues Under Non-Inflammatory Conditions, Despite Proper Expression of the Relevant Target Antigens.

Boris van der Zouwen, MD, Alwine B. Kruisselbrink, Peter A. Von Dem Borne, MD PhD, Roelof Willemze, MD PhD, J.H. Frederik Falkenburg, MD PhD, Inge Jedema, PhD
Journal: Blood
Blood (2009) 114 (22): 2454.
https://doi.org/10.1182/blood.V114.22.2454.2454
Published: 2009
Journal Articles

Collateral Damage: a Mechanism for Hematopoiesis-Restricted Mhag-Specific T Cells to Play a Role in the Effector Phase of GvHD.

Boris van der Zouwen, MD, Alwine B. Kruisselbrink, Peter A. Von Dem Borne, MD, PhD, Roelof Willemze, MD, PhD, J.H. Frederik Falkenburg, MD, PhD, Inge Jedema, PhD
Journal: Blood
Blood (2009) 114 (22): 3552.
https://doi.org/10.1182/blood.V114.22.3552.3552
Published: 2009